Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real World Use of Antidiabetic Drugs in the Years 2011-2017: A Population-Based Study from Southern Italy.
Ingrasciotta Y, Bertuccio MP, Crisafulli S, Ientile V, Muscianisi M, L'Abbate L, Pastorello M, Provenzano V, Scorsone A, Scondotto S, Trifirò G. Ingrasciotta Y, et al. Among authors: provenzano v. Int J Environ Res Public Health. 2020 Dec 18;17(24):9514. doi: 10.3390/ijerph17249514. Int J Environ Res Public Health. 2020. PMID: 33353081 Free PMC article.
Prognostic accuracy of continuous glucose monitoring in the prediction of diabetes mellitus in children with incidental hyperglycemia: receiver operating characteristic analysis.
Brancato D, Saura G, Fleres M, Ferrara L, Scorsone A, Aiello V, Di Noto A, Spano L, Provenzano V. Brancato D, et al. Among authors: provenzano v. Diabetes Technol Ther. 2013 Jul;15(7):580-5. doi: 10.1089/dia.2013.0030. Epub 2013 Apr 17. Diabetes Technol Ther. 2013. PMID: 23594031
Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in a Real-Life Setting: A 24-Month, Multicenter, Non-interventional, Retrospective Study.
Lapolla A, Berra C, Boemi M, Bossi AC, Candido R, Di Cianni G, Frontoni S, Genovese S, Ponzani P, Provenzano V, Russo GT, Sciangula L, Simioni N, Bette C, Nicolucci A; NN2211-4118 Study Group. Lapolla A, et al. Among authors: provenzano v. Adv Ther. 2018 Feb;35(2):243-253. doi: 10.1007/s12325-017-0652-2. Epub 2017 Dec 21. Adv Ther. 2018. PMID: 29270781 Free PMC article.
Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study.
Patti AM, Nikolic D, Magan-Fernandez A, Giglio RV, Castellino G, Chianetta R, Citarrella R, Corrado E, Provenzano F, Provenzano V, Montalto G, Rizvi AA, Rizzo M. Patti AM, et al. Among authors: provenzano v. Diabetes Res Clin Pract. 2019 Mar;149:163-169. doi: 10.1016/j.diabres.2019.02.006. Epub 2019 Feb 10. Diabetes Res Clin Pract. 2019. PMID: 30759365
Predictors of treatment response to liraglutide in type 2 diabetes in a real-world setting.
Simioni N, Berra C, Boemi M, Bossi AC, Candido R, Di Cianni G, Frontoni S, Genovese S, Ponzani P, Provenzano V, Russo GT, Sciangula L, Lapolla A, Bette C, Rossi MC; ReaL (NN2211-4118) Study Group*. Simioni N, et al. Among authors: provenzano v. Acta Diabetol. 2018 Jun;55(6):557-568. doi: 10.1007/s00592-018-1124-0. Epub 2018 Mar 12. Acta Diabetol. 2018. PMID: 29527621 Free PMC article.
Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study.
Rizzo M, Rizvi AA, Patti AM, Nikolic D, Giglio RV, Castellino G, Li Volti G, Caprio M, Montalto G, Provenzano V, Genovese S, Ceriello A. Rizzo M, et al. Among authors: provenzano v. Cardiovasc Diabetol. 2016 Dec 3;15(1):162. doi: 10.1186/s12933-016-0480-8. Cardiovasc Diabetol. 2016. PMID: 27912784 Free PMC article. Clinical Trial.
25 results